Related Experiment Video
Updated: Apr 19, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Variability in lipid profile among patients presented with acute myocardial infarction, unstable angina and stable
1Department of Cardiology, and Department of Cardiology Medicine, Tianjin Chest Hospital, Tianjin, China. qinqin6999@163.com.
Insights
Physicians hesitate to use lipid-lowering therapy in acute myocardial infarction (AMI) patients with low lipid levels. However, lower lipid levels in AMI are linked to inflammation, not a contraindication for therapy.
Area of Science:
- Cardiology
- Biochemistry
- Internal Medicine
Background:
- Coronary artery disease (CAD) management guidelines emphasize lipid-lowering therapy.
- Physicians express concern regarding initiating lipid-lowering therapy in acute myocardial infarction (AMI) patients presenting with low serum lipid levels.
- The adequacy of lipid-lowering therapy in AMI patients with low lipid profiles requires further exploration.
Purpose of the Study:
- To investigate the adequacy of lipid-lowering therapy in patients experiencing acute myocardial infarction (AMI).
- To analyze lipid profiles and clinical characteristics in different coronary artery disease (CAD) patient groups.
Main Methods:
- Collected lipid profile data from over 3000 coronary artery disease (CAD) patients.
- Categorized patients into three groups: acute myocardial infarction (AMI), stable angina pectoris (SAP), and unstable angina pectoris (UAP).
- Performed statistical analyses to compare baseline lipid levels and clinical features across the groups.
Main Results:
- Patients with AMI exhibited the lowest levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c) compared to UAP and SAP groups.
- Significant differences were observed in white blood count (WBC) and ejection fraction (EF) among the three groups.
- A strong correlation was found between ejection fraction (EF%) and lipid parameters (TC, LDL-c, HDL-c, non-HDL-c); WBC correlated with HDL-c only.
Conclusions:
- Lower lipid levels (TC, LDL-c, HDL-c) in AMI patients are associated with the acute inflammatory response during atherosclerotic plaque rupture.
- The acute inflammatory reaction in AMI influences lipid levels.
- Lipid-lowering therapy should be initiated promptly in AMI patients, irrespective of their baseline lower lipid levels.
Objective:
Despite the amply evidence and guidelines in treating coronary artery disease (CAD) with lipid-lowering therapy, physicians still have concerns in treating acute myocardial infarction (AMI) patients who have the low serum lipid level. We explored the adequacy of lipid-lowering therapy in treating AMI patients.
Patients And Methods:
Over 3000 CAD lipid profile data were collected, their data were divided into 3 groups (AMI; stable angina pectoris (SAP) and unstable angina pectoris (UAP) group) based their clinical characteristics. Statistical analyses were performed to compare their baseline lipid levels and clinical feature.
Results:
The total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c) and high-density lipoprotein cholesterol (HDL-c) level in AMI patients were the lowest, followed by UAP patient group and SAP patient group. There were significant differences in white blood count (WBC) and ejection fraction (EF) between 3 groups. A good correlation was confirmed between EF% and the lipid parameters of TC, LDL-c, HDL-c, non-HDL-c. WBC did not correlate with the lipid except HDL-c. AMI is an acute inflammatory reaction that is accompanied with the change of lipid level.
Conclusions:
Although the level of TC, LDL-c and HDL-c are lower in AMI, but it is related with acute inflammatory reaction during the rupture of atherosclerotic plaques. Lipid-lowering therapy should not be delayed in treating AMI patients with lower lipid level.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Angina IV: Management
Angina II: Classification
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome I: Introduction